← Open Payments lookup

CASEY BUTTS: Open Payments

NPI 1154725075 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$380 in 21 payments from 11 companies in 2025. Trend: 2023 $578 · 2024 $390 · 2025 $380

Food & beverage: $380
CompanyPaymentsAmount
Astellas Pharma US Inc8$170
Sumitomo Pharma America, Inc.3$52
Amneal Pharmaceuticals LLC2$29
IBSA Pharma Inc.1$21
Lilly USA, LLC1$18
Bayer Healthcare Pharmaceuticals Inc.1$17
Currax Pharmaceuticals LLC1$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$15
Acella Pharmaceuticals, LLC1$15
PFIZER INC.1$14

Products named: Veozah, MYFEMBREE, UNITHROID, Tirosint, ZEPBOUND, Lynkuet, ONZETRA XSAIL, XIFAXAN.

Industry payments across OK — which companies pay providers there.